HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
COMPANY
Gland Pharma gets GMP Compliance Certificate for Pashamylaram facility
Jul-14-2025

Gland Pharma has received certificate of Good Manufacturing Practices (GMP) Compliance for its Pashamylaram facility from Danish Medicines Agency in connection with Marketing authorizations listing manufacturers located outside of the European Economic Area, for aseptically prepared Powder for injection, infusion and inhalation. 

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

  RELATED NEWS >>